Transarterial radioembolization to treat primary or secondary liver cancer, D Schnappauf

Поделиться
HTML-код
  • Опубликовано: 11 сен 2024

Комментарии • 2

  • @livinggoodnatural8984
    @livinggoodnatural8984 5 лет назад

    Why not do the surgery, cut off the part of the cancer cells and let the patients live? If you do this, the patients only live for 3 months, then I don't think it's worthy for trouble and the sufferings. The patients might just go ahead and do the "natural cure" and probably will get much better result.

    • @iprateek07
      @iprateek07 3 года назад

      Hepatocellular ca is agressive plus there is a feild defect , plus it occurs in a damaged liver, even after surgery these patients live lesser than 3 months , plus doing surgery in liver compromised patients kills >30% of the patients with surgery itself . These are only a minority of the reasons TARE has a role over surgery in this specific subset. Surgery definetly has a role in HCC , but thats a big different subject